2026 NPPES data Neuroscience Registered Nurse NPI 1245838390
Verify on CMS →

SARAH LUPPINO

Neuroscience Registered Nurse in BOSTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
189
Medicare Part D claims · 37 beneficiaries · Neuroscience Registered Nurse avg: 1K
Generic prescribing
58%
generic claims · 42% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.2K
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: SARAH LUPPINO is a Neuroscience Registered Nurse ([object Object]) practicing in BOSTON, Massachusetts with a Medicare Part D prescribing footprint of 189 claims across 37 beneficiaries — 42% brand-name prescribing . Industry payments of $1.2K across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: SARAH LUPPINO filed 189 Medicare Part D claims in 2023 across BOSTON, Massachusetts. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

SARAH LUPPINO at a glance

Quality data not reported

NPI registry status

Active

Issued 10/12/2020

NPI 1245838390

Primary specialty

Neuroscience Registered Nurse

Rare

292 US NPIs in this specialty

Medicare Part D claims

189 81% vs specialty avg

2023 prescription claims

Specialty avg: 1,016

Specialty distribution in Massachusetts

How Neuroscience Registered Nurse compares to other specialties among Massachusetts providers

Massachusetts providers

Neuroscience Registered Nurse share within Massachusetts

1. Neuroscience Registered Nurse42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Neuroscience Registered Nurse share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Neuroscience Registered Nurse (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Neuroscience Registered Nurse ABMS/AOA estimate

Est. board-certified rate (Neuroscience Registered Nurse) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Neuroscience Registered Nurse) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SARAH LUPPINO is a Neuroscience Registered Nurse provider practicing in BOSTON, Massachusetts, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1245838390. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

SARAH LUPPINO appears in the CMS NPPES registry as a Neuroscience Registered Nurse provider at 165 CAMBRIDGE ST STE 6, BOSTON, MA, 02114, with a listed phone of (617) 724-3380. NPI 1245838390 was issued on 10/12/2020. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LUPPINO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 189 prescription claims written by this provider, covering 37 Medicare beneficiaries and totaling roughly $887K in drug spend, split 42% brand-name and 58% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Neuroscience Registered Nurse is a narrow specialty nationwide, with 292 enrolled providers across 43 states and an average of 1,016 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

165 CAMBRIDGE ST STE 6
BOSTON, MA 02114

Provider Details

NPI 1245838390
Specialty Neuroscience Registered Nurse
Gender Female
NPI Issued 10/12/2020

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SARAH LUPPINO. Source: openpaymentsdata.cms.gov.

Total received

$1.2K

Largest payer

GENZYME CORPORATION

Most common payment type

Consulting Fee

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to SARAH LUPPINO. To verify SARAH LUPPINO's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

SARAH LUPPINO — brand share 42.0%
Specialty average (est.)

42% brand-name claims vs 58% generic, on 189 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

189
Total Claims
$887K
Total Drug Cost
37
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
243
Total Day Supply
6,705
Brand vs Generic
42% brand / 58% generic
Brand Drug Cost
$876K
Generic Drug Cost
$11K

Patient Demographics

Average Patient Age
68.9 years
Avg HCC Risk Score
2.27
Gender Split
46% female / 54% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Radicava Ors
Edaravone
40
Riluzole
37
Relyvrio
Sod Phenylbutyrat/Taurursodiol
24
Atropine Sulfate
15

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neuroscience Registered Nurse Overview

How SARAH LUPPINO fits within the Neuroscience Registered Nurse landscape nationally.

292
Neuroscience Registered Nurse Providers in US
43
States with Neuroscience Registered Nurse
1,016
Avg Claims per Provider

SARAH LUPPINO's 189 claims are below the specialty average of 1,016.

Nearby Neuroscience Registered Nurse Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as LUPPINO.

Compare Neuroscience Registered Nurse nationally: see state-by-state distribution →

Frequently Asked Questions

What is SARAH LUPPINO's specialty?
SARAH LUPPINO specializes in Neuroscience Registered Nurse and practices in BOSTON, Massachusetts.
How much does SARAH LUPPINO prescribe under Medicare Part D?
In 2023, SARAH LUPPINO wrote 189 Medicare Part D claims totaling $887K in drug costs for 37 beneficiaries.
Where is SARAH LUPPINO located?
SARAH LUPPINO is located at 165 CAMBRIDGE ST STE 6, BOSTON, MA, 02114. Phone: (617) 724-3380.
What is SARAH LUPPINO's NPI number?
SARAH LUPPINO's National Provider Identifier (NPI) is 1245838390, issued on 10/12/2020.
Does SARAH LUPPINO prescribe more brand-name or generic drugs?
SARAH LUPPINO's prescribing is 42% brand-name and 58% generic drugs by claim count, with $876K in brand drug costs.
How many Neuroscience Registered Nurse providers are there in the US?
There are 292 Neuroscience Registered Nurse providers across 43 states in the US. The average Neuroscience Registered Nurse provider writes 1,016 Medicare Part D claims per year.
What drugs does SARAH LUPPINO prescribe most often?
Based on 2023 Medicare Part D data, SARAH LUPPINO's most frequently prescribed drugs include Radicava Ors, Riluzole, Relyvrio. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SARAH LUPPINO accept Medicare?
SARAH LUPPINO appears in CMS Medicare data with 189 Part D claims and 37 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SARAH LUPPINO's credentials?
SARAH LUPPINO's NPI is 1245838390. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology